Search Results - Gummer, J.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    A comparative analysis of the heterotrimeric G-protein G[alpha], G[beta] and G[gamma] subunits in the wheat pathogen Stagonospora nodorum

    A comparative analysis of the heterotrimeric G-protein G[alpha], G[beta] and G[gamma] subunits in the wheat pathogen Stagonospora nodorum by Gummer, J., Trengove, R., Oliver, Richard, Solomon, P.

    Published 2012
    Get full text
  2. 2
    Dissecting the role of G-protein signalling in primary metabolism in the wheat pathogen Stagonospora nodorum

    Dissecting the role of G-protein signalling in primary metabolism in the wheat pathogen Stagonospora nodorum by Gummer, J., Trengove, R., Oliver, Richard, Solomon, P.

    Published 2013
    Get full text
  3. 3
    A rapid method for profiling of volatile and semi-volatile phytohormones using methyl chloroformate derivatisation and GC–MS

    A rapid method for profiling of volatile and semi-volatile phytohormones using methyl chloroformate derivatisation and GC–MS by Rawlinson, C., Kamphuis, L., Gummer, J., Singh, Karambir, Trengove, R.

    Published 2015
    Get full text
  4. 4
    Dysregulated erythropoietin, hepcidin, and bone marrow iron metabolism contribute to interferon-induced anemia in hepatitis C

    Dysregulated erythropoietin, hepcidin, and bone marrow iron metabolism contribute to interferon-induced anemia in hepatitis C by Van Rijnsoever, M., Galhenage, S., Mollison, L., Gummer, J., Trengove, R., Olynyk, John

    Published 2016
    Get full text
  5. 5
    Metabolomics protocols for filamentous fungi

    Metabolomics protocols for filamentous fungi by Gummer, J., Krill, C., du Fall, L., Waters, O., Trengove, R., Oliver, Richard, Solomon, P.

    Published 2012
    Get full text
  6. 6
    Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness

    Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness by The, I., Litton, E., Baker, S., Erber, W., Farmer, Shannon, Ferrier, J., French, C., Gummer, J., Hawkins, D., Higgins, A., Hofmann, Axel, De Keulenaer, B., McMorrow, J., Olynyk, John, Richards, T., Towler, S., Trengove, R., Webb, S., The, A.

    Published 2016
    Get full text
  7. 7
    Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

    Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial by Gummer, J., Trengove, R., Pascoe, E., Badve, S., Cass, A., Clarke, P., McDonald, S., Morrish, A., Pedagogos, E., Perkovic, V., Reidlinger, D., Scaria, A., Walker, R., Vergara, L., Hawley, C., Johnson, D., Olynyk, John, Ferrari, P.

    Published 2017
    Get full text
  8. 8
    Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: A nested cohort study

    Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: A nested cohort study by Litton, E., Baker, S., Erber, W., Farmer, Shannon, Ferrier, J., French, C., Gummer, J., Hawkins, D., Higgins, A., Hofmann, A., De Keulenaer, B., McMorrow, J., Olynyk, John, Richards, T., Towler, S., Trengove, R., Webb, S., Chapman, A., Jenkinson, E., Palermo, A., Roberts, B.

    Published 2018
    Get full text

Search Tools: